Amikacin Liposome Inhalation Suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amikacin Liposome Inhalation Suspension, covering 2025-11-19 to 2025-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection [Phase 2]